Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells-Reference-Cited by-同舟云学术

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells

Published:2020-02-11 Issue: Volume:11 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Michmerhuizen Anna R.,Chandler Benjamin,Olsen Eric,Wilder-Romans Kari,Moubadder Leah,Liu Meilan,Pesch Andrea M.,Zhang Amanda,Ritter Cassandra,Ward S. Tanner,Santola Alyssa,Nyati Shyam,Rae James M.,Hayes Daniel,Feng Felix Y.,Spratt Daniel,Wahl Daniel,Eisner Joel,Pierce Lori J.,Speers Corey

Funder

Breast Cancer Research Foundation

Comprehensive Cancer Center, University of Michigan

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference46 articles.

1. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the danish breast cancer cooperative group;Kyndi;JCO.,2008

2. Molecular heterogeneity of triple negative breast cancer;Abramson;Curr Breast Cancer Rep.,2014

3. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment;Garrido-Castro;Cancer Discov.,2019

4. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis;Bareche;Ann Oncol.,2018

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Changes in Breast Cancer Induced by Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Breast Cancer Treatment: To tARget or Not? That Is the Question;Cancers;2023-11-30

3. The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer;Cancers;2023-09-24

4. Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity;International Journal of Biomedicine;2023-09-05

5. Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review;Biomedicines;2023-06-20